ArticleFrontiers in pharmacology2025
Deep learning-based action recognition for analyzing drug-induced bone remodeling mechanisms.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Understanding the mechanisms of drug-induced bone remodeling is critical for optimizing therapeutic interventions and minimizing adverse effects in bone health management. Bone remodeling is a highly dynamic process that involves the intricate interplay between osteoblasts, osteoclasts, and osteocytes, regulated by a complex network of signaling pathways and molecular interactions. Traditional experimental and computational approaches often fail to capture this dynamic and multi-scale nature, particularly when influenced by pharmacological agents, which can have both therapeutic and adverse effects. Methods: In this work, we present a novel deep learning-based framework for action recognition, specifically designed to analyze drug-induced bone remodeling mechanisms. Our framework leverages graph neural networks (GNNs) to model the spatial and temporal dependencies of multi-scale biological data, combined with a dynamic signal propagation model to identify key molecular interactions driving bone remodeling. A predictive pharmacological interaction model is integrated to quantify drug-target interactions, assess their systemic impacts, and simulate off-target effects. This approach also evaluates combinatorial drug effects, offering insights into the synergistic or antagonistic behaviors of multiple agents. Results: By incorporating these features, our method provides a comprehensive view of drug-induced changes, enabling accurate prediction of their effects on bone formation and resorption pathways. Discussion: Experimental results highlight the model's potential to advance precision medicine, enabling the development of more effective and safer therapeutic strategies for managing bone health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.